Gencia and Takeda to develop novel mitochondrial therapeutics
11 September 2015 | By Victoria White
Gencia and Takeda aim to jointly research and develop two preclinical drug candidates, one each in the areas of inflammation and oncology...
List view / Grid view
News
SAS1B discovery could fundamentally alter cancer treatment
10 September 2015 | By Victoria White
The SAS1B protein appears only on egg cells and cancer cells, and could serve as a target for tiny tracking probes created using monoclonal antibodies...
MGB Biopharma wins Scottish Business Award
10 September 2015 | By Victoria White
MGB Biopharma was one of three shortlisted finalists for the “Early Stage/ Risk Capital Deal of the Year” category which is awarded for a deal made by an early stage company...
Blueprint Medicines to advance BLU-285 in Phase 1 trial for systemic mastocytosis
10 September 2015 | By Victoria White
BLU-285 is a potent and highly selective inhibitor of the KIT D816V mutant, the primary driver of disease in more than 94% of systemic mastocytosis patients...
Pretreated monocytes may confer positive effects for Alzheimer’s sufferers
10 September 2015 | By Victoria White
Administration of human umbilical cord blood cell-derived monocytes diminished Aβ pathology in test models and also improved hippocampal-dependent learning, memory and motor function...
Scientists make biodegradable pharmaceuticals
9 September 2015 | By Victoria White
Scientists from Leuphana University Lüneburg have developed a way to make drugs that break down into harmless compounds before they contaminate our water supply...
TxCell announces preclinical efficacy results for Col-Treg in autoimmune uveitis
9 September 2015 | By Victoria White
In vivo administration of Col-Treg in the model of autoimmune uveitis significantly inhibited clinical symptoms, retinal tissue lesions as well as ocular proinflammatory cell infiltration...
Testicular cancer found to be ‘strongly heritable’
9 September 2015 | By Victoria White
New research suggests genetic inheritance is much more important in testicular cancer than in most other cancer types, where genetics typically accounts for less than 20% of risk...
Researchers win EBF funding to advance Wolfram syndrome project
8 September 2015 | By Victoria White
A University of Birmingham research team, developing a treatment for Wolfram Syndrome, has secured £17,000 from the Enterprising Birmingham Fund...
AMRA and Pfizer team up for MR imaging project
8 September 2015 | By Victoria White
AMRA will collaborate with Pfizer to help provide a better understanding of the relationship between body composition and risk for obesity related diseases...
Pierre Fabre and Addex sign early-stage agreement in CNS field
8 September 2015 | By Victoria White
Addex Therapeutics has granted an option to license its metabotropic glutamate receptor subtype 3 (mGlu3 receptor) programme to Pierre Fabre...
ReViral announces $21m fundraising to advance RSV drug
8 September 2015 | By Victoria White
The funding will enable ReViral to progress its lead drug candidate, RV521, into proof of concept clinical trials and to continue the development of a novel series of antiviral inhibitors...
Kymab on Sunday Times Tech Track ‘Ones to Watch’ list
7 September 2015 | By Victoria White
The ranking recognises Kymab’s potential for rapid future sales growth and increasing international presence...
Immunocore ranks high in the Sunday Times Hiscox Tech Track 100
7 September 2015 | By Victoria White
Immunocore has been ranked as the Number one company in the southeast region of the UK and number nine overall in the Sunday Times Hiscox Tech Track 100...
Inhaled dosage form of BAL30072 to be formulated for patients with cystic fibrosis
7 September 2015 | By Victoria White
Basilea is to work with the iABC consortium to develop an inhaled formulation of its antibiotic BAL30072 as part of a new Europe-wide programme...